LOS ANGELES, CA — The Citizens Commission on Human Rights International (CCHR), a mental health industry watchdog, is reminding parents of a federal law it helped secure in 2004 that prohibits schools from mandating psychiatric drugs for children as a condition of attendance. The Prohibition on Mandatory Medication Amendment, now part of the Code of Federal Regulations, was a response to widespread reports of school personnel coercing parents through threats of expulsion, involvement of Child Protective Services, or criminal charges of medical neglect. This protection remains critical as new government actions echo CCHR's decades-long advocacy for informed consent and drug safety.
The 2004 law, codified at 34 C.F.R. § 300.174, was passed after years of documented cases where families faced severe consequences if they refused to place their children on antidepressants or other psychotropic drugs. Many children suffered debilitating side effects, and some died by suicide. CCHR's efforts were praised by Congressman Dan Burton, who said, "Through united action, effective education and advocacy, CCHR has helped to bring about critically needed healthcare reform." A senior staffer on the Government Reform Committee noted, "The most important impact CCHR has made was the increased awareness on Capitol Hill—that we are forcing medication through schools."
Recent developments underscore the ongoing relevance of these protections. In May 2026, the U.S. Department of Health and Human Services announced a plan to curb psychiatric overprescribing and support safe withdrawal from antidepressants, a clear endorsement of deprescribing. On July 24, 2026, Florida Surgeon General Dr. Joseph A. Ladapo issued guidance recommending against the use of psychotropic drugs in children aged 5–17 for mental health conditions, emphasizing the need for thorough physical examinations before any treatment. The United Kingdom had already taken similar steps in 2024.
CCHR's role in the 2004 law was significant. The group worked with AbleChild.org and the National Foundation of Women Legislators to pass similar prohibitions in 12 states, building momentum for the federal effort. At the time, a Roll Call article noted that the psychiatric lobby was caught off-guard by the legislation's support. The need for such protections grew directly from CCHR's documentation of coercive practices.
CCHR was also the first patient advocacy group to pressure the FDA to hold a public hearing on antidepressant-induced suicide and violence, which occurred on September 20, 1991. Despite compelling testimony from dozens of patients and family members, the majority of the advisory panel—many with financial ties to pharmaceutical companies—voted against label changes. It took another 13 years of persistent advocacy before the FDA added black-box warnings about suicidal ideation to SSRI antidepressants.
Celebrities like the late Kirstie Alley and Kelly Preston, both CCHR board members, publicly supported the federal law and testified before the Florida state legislature in 2005. CCHR Florida has continued to raise alarms about children being drugged while under involuntary psychiatric detention.
Jan Eastgate, President of CCHR International, stated: "The risk data was always available for anyone willing to listen to patients or press for the facts, and thanks to those who did, there is a cultural shift in the recognition of psychotropic drug risks and the need to be able to safely withdraw from them. They should never be forced onto any child or individual."
The Florida guidance also aligns with CCHR's long-standing advocacy for physical examinations before psychiatric treatment. As early as 1982, CCHR campaigned for California Senate Bill 929, which established a pilot project to provide medical evaluations for people in public psychiatric hospitals. The findings, published in 1989, showed that many patients had undiagnosed physical diseases that contributed to their psychiatric symptoms.
For over four decades, CCHR—established by the Church of Scientology and psychiatrist Dr. Thomas Szasz—has worked to protect parental and children's rights and ensure true informed consent. The recent federal and state actions mark a significant shift in recognizing the risks of psychiatric drugs and the importance of deprescribing, a cause CCHR has championed for years.
